FBLG · FibroBiologics Inc
United States · RS rating 23 · As of 2026-10-14
| Price | 0.95 USD |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 23 / 5 / 88 / 4 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 11 / 50 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +50.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +89.4% |
| Market cap (USD) | $6.9M |